PHARMACOKINETICS OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR FOR TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS IN CHILDREN

被引：0
|
作者：
Relan, A.
Reshef, A.
Grivcheva-Panovska, V.
Kessel, A.
Kivity, S.
Klimaszewska-Rembiasz, M.
Moldovan, D.
Farkas, H.
Gutova, V.
Fritz, S.
Bellizzi, L.
Giannetti, B.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.113
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P165
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [31] Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema
    Bork, Konrad
    Craig, Timothy J.
    Bernstein, Jonathan A.
    Feuersenger, Henrike
    Machnig, Thomas
    Staubach, Petra
    ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (03) : 218 - 224
  • [32] Use of nanofiltered C1 esterase inhibitor (human) for the treatment of gastrointestinal attacks in subjects with hereditary angioedema
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Riedl, M.
    Busse, P.
    Grant, A.
    Mariano, D.
    Kalfus, I
    ALLERGY, 2011, 66 : 418 - 419
  • [33] Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema
    Farrell, Colm
    Hayes, Siobhan
    Relan, Anurag
    van Amersfoort, Edwin S.
    Pijpstra, Rienk
    Hack, C. Erik
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (06) : 897 - 907
  • [34] THE C1 ESTERASE INHIBITOR AND HEREDITARY ANGIOEDEMA
    FRANK, MM
    JOURNAL OF CLINICAL IMMUNOLOGY, 1982, 2 (02) : 65 - 68
  • [35] Effect of C1 esterase inhibitor in hereditary angioedema treatment
    Gurmen, Ekim Saglam
    Dogan, Serkan
    Sert, Eren
    Dikmetas, Cesareddin
    Hussein, Sennaz
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (06): : 942.e5 - 942.e6
  • [36] Efficacy of recombinant human c1 esterase inhibitor as prophylaxis for hereditary angioedema attacks in a patient tolerant to other therapies
    Jones, D. H.
    Park, N.
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) : 258 - 258
  • [37] Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
    Sabharwal, Geetika
    Craig, Timothy
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (03) : 319 - 327
  • [38] Recombinant human C1 esterase inhibitor for the acute treatment of hereditary angioedema attacks: Multi-country, European registry analysis
    Hakl, R.
    Valerieva, A.
    Staevska, M.
    Kohalmi, Viktoria K.
    Farkas, H.
    Jesenak, M.
    Zanichelli, A.
    Hrubiskova, K.
    Grivcheva-Panovska, V
    Bellizzi, L.
    Relan, A.
    Cicardi, M.
    ALLERGY, 2019, 74 : 271 - 271
  • [39] Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks
    Li, H. Henry
    Aygoeren-Puersuen, Emel
    Magerl, Markus
    Craig, Timothy J.
    Manning, Michael E.
    Hummel, Noemi
    Kopiec, Agnieszka
    Fu, Shuai
    Morris, James
    Wang, Alice
    Audhya, Paul K.
    Bernstein, Jonathan A.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2025, 21 (01):
  • [40] Safety, efficacy, and pharmacokinetics of intravenous C1 esterase inhibitor (human) prophylaxis in children with hereditary angioedema (HAE)
    Soteres, Daniel F.
    Aygoren-Pursun, Emel
    Nieto-Martinez, Sandra A.
    Christensen, Jim
    Jacobson, Kraig W.
    Moldovan, Dumitru
    Kivity, Shmuel
    Vardi, Moshe
    Baptista, Jovanna
    Martinez-Saguer, Inmaculada
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB42 - AB42
12345